← Back to Search

Convoy-Pal for Multiple Chronic Conditions (ConvoyPal Trial)

N/A

Waitlist Available

Led By Jennifer D Portz, PhD, MSW

Research Sponsored by University of Colorado, Denver

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

ConvoyPal Trial Summary

This trial is testing a mobile intervention called Convoy-Pal among older adults to see if it's feasible and usable. 40 patients and their social support networks will be randomized to either use Convoy-Pal or be on a waitlist. Feasibility will be measured by recruitment, attrition, and data collection on quality of life and social support. Usability will be captured by self-report usability scales and actual back end utilization data.

Eligible Conditions

Multiple Chronic Conditions

ConvoyPal Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

User Mobile Application Rating Scale

ConvoyPal Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Convoy-Pal InterventionExperimental Treatment1 Intervention

Intervention participants will be sent Convoy-Pal equipment and materials. The equipment can simply be removed from the box, plugged in, and turned on to start. Research staff will provide technical support as needed during the trial. Convoy-Pal is 12-week intervention that uses the Routinify platform to deliver self-management tools and palliative care resources in the participants' home. The platform includes a tablet, charging stand, and smart watch, with additional options for mobile phone access and a website portal.

Group II: Waitlist ControlActive Control1 Intervention

Participants will complete baseline assessments and will be recontacted at 11 weeks to complete follow up assessments at week 12. Participants will receive a $25 gift card for each assessment ($50 total). If they would like to try the intervention at that time, we will send them Convoy-Pal equipment and materials. They will then have 12 weeks to use the tool.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Convoy-Pal

2021

N/A

~40

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor

1,732 Previous Clinical Trials

2,143,544 Total Patients Enrolled

National Institute on Aging (NIA)NIH

1,671 Previous Clinical Trials

28,017,024 Total Patients Enrolled

3 Trials studying Multiple Chronic Conditions

201 Patients Enrolled for Multiple Chronic Conditions

Jennifer D Portz, PhD, MSWPrincipal InvestigatorUniversity of Colorado Denver | Anschutz

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this investigation recruiting participants currently?

"The information located on clinicaltrials.gov verifies that this experimental study is still enrolling participants, having been first uploaded to the website in April 2021 and last updated a month ago in May 2022."

Answered by AI

What is the total enrollment of participants for this trial?

"Affirmative, clinicaltrials.gov verifies that the trial is still open to participants. This research project was first posted on April 1st 2021 and has been amended as recently as May 16th 2022. A total of 40 patients are needed at a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Social Convoy Palliative Care (Convoy-Pal) Mobile Health for Older Adults

2021. "Social Convoy Palliative Care (Convoy-Pal) Mobile Health for Older Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04779931.